FREE Account Opening + No Clearing Fees
Loading...
September 1, 2021 - September 3, 2021

Vijaya Diagnostic IPO Review & Recommendations

Arihant Capital Markets Ltd, Hem Securities, IIFL Securities, KR Choksey Securities Ltd, Marwadi Shares and Finance Ltd, Mehta Equities, Reliance Securities and Ventura Securities Limited have given "Apply" recommendation to Vijaya Diagnostic IPO. Dilip Davda has given "May Apply" recommendation to Vijaya Diagnostic IPO. Axis Capital, HDFC Securities Limited, JM Financial Institutional Securities, Kotak Securities and Religare Broking Limited have "Neutral" view about the IPO. Capital Market and InvestorGain.com recommend to "Avoid" the IPO.

Vijaya Diagnostic IPO Review Summary from brokers and analysts

Review By Apply May Apply Neutral Avoid Not Rated
Count 8 1 5 2 0
% 50.00 6.25 31.25 12.50 0.00

Vijaya Diagnostic IPO Capital Market Rating

The Captial Market (CapitalMarket.com) rating for Vijaya Diagnostic IPO is 40. Their analysis recommends Avoid, however active risk seekers can try for the IPO.

Reviewer Rating Score Rating
Capital Market 40 Avoid, however active risk seekers can try

Vijaya Diagnostic IPO Review by Dilip Davda (May apply)

[Dilip Davda]  This is a majorly south centric diagnostic service provider. The issue is fully priced based on its super performance so far. The segment is getting crowded post-pandemic and thus creating high competition going forward. The recent IPO of south based Krsnaa Diagnostic performed miserably post a listing. This is a pure secondary offer. Considering all these parameters, risk seekers/cash surplus investors may consider an investment with a long term perspective. Read detail review...

Post Recommendation Manage Recommendations

Note:

  • The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
  • We reserve the right to remove any objectionable post without providing a reason.